Advisory Resource Group Has $1.08 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Advisory Resource Group lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 18.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,703 shares of the biotechnology company’s stock after selling 629 shares during the period. Advisory Resource Group’s holdings in Axon Enterprise were worth $1,080,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in AXON. Blue Trust Inc. boosted its holdings in shares of Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after buying an additional 79 shares during the period. Quent Capital LLC lifted its position in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise in the third quarter valued at about $41,000. Finally, Asset Dedication LLC bought a new position in shares of Axon Enterprise in the second quarter worth about $47,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 0.8 %

Shares of AXON stock opened at $642.45 on Thursday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $48.99 billion, a P/E ratio of 166.01, a P/E/G ratio of 15.13 and a beta of 1.01. Axon Enterprise, Inc. has a 12-month low of $238.07 and a 12-month high of $698.67. The firm has a 50-day moving average price of $530.63 and a 200 day moving average price of $400.50.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on AXON. The Goldman Sachs Group raised their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. JMP Securities boosted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $488.67.

Insider Buying and Selling at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $380.99, for a total transaction of $380,990.00. Following the transaction, the director now owns 27,259 shares of the company’s stock, valued at $10,385,406.41. This represents a 3.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 47,314 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $400.07, for a total value of $18,928,911.98. Following the completion of the transaction, the chief executive officer now owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. This represents a 1.56 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 99,590 shares of company stock worth $49,176,907. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.